The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
The Significant Effect of Diabetes Duration on Coronary Heart Disease Mortality
Open accessAbstract
OBJECTIVE—The risk of coronary heart disease (CHD) in type 2 diabetes is two- to threefold higher than in the general population, but the effect of diabetes duration on CHD risk has not been well characterized. We hypothesized that duration of diabetes is an important predictor of incident CHD among people with diabetes. RESEARCH DESIGN AND METHODS—The duration of diabetes (fasting glucose ≥126 mg/dl, random glucose ≥200 mg/dl, or use of an oral hypoglycemic agent or insulin) was assessed in participants with diabetes in the original and offspring cohorts of the Framingham Heart Study. Only subjects with diabetes diagnosed between the ages of 30 and 74 years, without a history of ketoacidosis, and free of cardiovascular disease at the baseline evaluation were included. Cox proportional hazards models were used to estimate the hazard ratio of incident CHD events and mortality over a 12-year follow-up period; models were adjusted for known CHD risk factors. RESULTS—Among 588 person-exams with diabetes (mean age 58 ± 9 years, 56% men), there were 86 CHD events, including 36 deaths. After adjustment for age, sex, and CHD risk factors, the risk of CHD was 1.38 times higher for each 10-year increase in duration of diabetes (95% CI 0.99–1.92), and the risk for CHD death was 1.86 times higher (1.17–2.93) for the same increase in duration of diabetes. CONCLUSIONS—Duration of diabetes increases the risk of CHD death independent of coexisting risk factors. Further research is necessary to understand the pathophysiology of this increased risk.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gerstein, H. C. (2001) · JAMA · doi:10.1001/jama.286.4.421 · Cited by 2,440
D'Agostino, R. B., Grundy, S., Sullivan, L. M., Wilson, P., & for the CHD Risk Prediction Group (2001) · JAMA · doi:10.1001/jama.286.2.180 · Cited by 2,108
Self-citationImpact of Reduced Heart Rate Variability on Risk for Cardiac Events: The Framingham Heart Study
Tsuji, H., Larson, M. G., Venditti, F. J., Manders, E. S., Evans, J. C., Feldman, C. L., & Levy, D. (1996) · Circulation · doi:10.1161/01.cir.94.11.2850 · Cited by 1,762
Comparison of Coronary Bypass Surgery with Angioplasty in Patients with Multivessel Disease
(1996) · New England Journal of Medicine · doi:10.1056/nejm199607253350401 · Cited by 1,531
Onset of NIDDM occurs at Least 4–7 yr Before Clinical Diagnosis
Harris, M. I., Klein, R., Welborn, T. A., & Knuiman, M. W. (1992) · Diabetes Care · doi:10.2337/diacare.15.7.815 · Cited by 1,306
Keaney, J. F., Larson, M. G., Vasan, R. S., Wilson, P. W. F., Lipinska, I., Corey, D., Massaro, J. M., Sutherland, P., Vita, J. A., & Benjamin, E. J. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000058402.34138.11 · Cited by 1,304
Self-citationDiabetes and Glucose Tolerance as Risk Factors for Cardiovascular Disease: The Framingham Study
Kannel, W. B., & McGee, D. L. (1979) · Diabetes Care · doi:10.2337/diacare.2.2.120 · Cited by 1,203 · cited 1×
“T ype 2 diabetes confers a two- to threefold increase in the risk of cardiovascular disease (CVD) (1).”
BackgroundAppointment of New Associate Editor for Circulation
Willerson, J. T. (1996) · Circulation · doi:10.1161/01.cir.94.6.1193 · Cited by 954
The framingham offspring study. Design and preliminary data
Feinleib, M., Kannel, W. B., Garrison, R. J., McNamara, P. M., & Castelli, W. P. (1975) · Preventive Medicine · doi:10.1016/0091-7435(75)90037-7 · Cited by 930
La Rovere, M. T., Pinna, G. D., Maestri, R., Mortara, A., Capomolla, S., Febo, O., Ferrari, R., Franchini, M., Gnemmi, M., Opasich, C., et al. (2003) · Circulation · doi:10.1161/01.cir.0000047275.25795.17 · Cited by 917
Effect of Diabetes Mellitus on Formation of Coronary Collateral Vessels
Abacı, A., Oğuzhan, A., Kahraman, S., Eryol, N. K., Ünal, S., Arınç, H., & Ergin, A. (1999) · Circulation · doi:10.1161/01.cir.99.17.2239 · Cited by 627
AN APPROACH TO LONGITUDINAL STUDIES IN A COMMUNITY: THE FRAMINGHAM STUDY
Dawber, T. R., Kannel, W. B., & Lyell, L. P. (1963) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1963.tb13299.x · Cited by 560
Orchard, T. J., Dorman, J. S., Maser, R. E., Becker, D. J., Drash, A. L., Ellis, D., LaPorte, R. E., & Kuller, L. H. (1990) · Diabetes · doi:10.2337/diab.39.9.1116 · Cited by 540
Hyperinsulinemia, Hyperglycemia, and Impaired Hemostasis: The Framingham Offspring Study
Meigs, J. B., Mittleman, M. A., Nathan, D. M., Tofler, G. H., Singer, D. E., Murphy-Sheehy, P. M., Lipinska, I., D'Agostino, R. B., & Wilson, P. W. F. (2000) · JAMA · doi:10.1001/jama.283.2.221 · Cited by 538
Self-citationHu, F. B., Stampfer, M. J., Solomon, C. G., Liu, S., Willett, W. C., Speizer, F. E., Nathan, D. M., & Manson, J. E. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.14.1717 · Cited by 534
Association of hyperglycemia with reduced heart rate variability (The Framingham Heart Study)
Singh, J. P., Larson, M. G., O’Donnell, C. J., Wilson, P. F., Tsuji, H., Lloyd-Jones, D. M., & Levy, D. (2000) · The American Journal of Cardiology · doi:10.1016/s0002-9149(00)00920-6 · Cited by 439
Self-citationClarkson, P., Celermajer, D. S., Donald, A. E., Sampson, M., Sorensen, K. E., Adams, M., Yue, D. K., John Betteridge, D., & Deanfield, J. E. (1996) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(96)82380-1 · Cited by 420
Diabetes, fibrinogen, and risk of cardiovascular disease: The Framingham experience
Kannel, W. B., D'Agostino, R. B., Wilson, P. W. F., Belanger, A. J., & Gagnon, D. R. (1990) · American Heart Journal · doi:10.1016/0002-8703(90)90026-t · Cited by 368
Self-citationAcute myocardial infarction in the diabetic patient: Pathophysiology, clinical course and prognosis
Jacoby, R. M., & Nesto, R. W. (1992) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(92)90033-j · Cited by 349
Lieberman, E. H., Gerhard, M. D., Uehata, A., Selwyn, A. P., Ganz, P., Yeung, A. C., & Creager, M. A. (1996) · The American Journal of Cardiology · doi:10.1016/s0002-9149(96)00597-8 · Cited by 318
Tuomilehto, J., Borch-Johnsen, K., Molarius, A., Forsén, T., Rastenyte, D., Sarti, C., & Reunanen, A. (1998) · Diabetologia · doi:10.1007/s001250050988 · Cited by 226
Cho, E., Rimm, E. B., Stampfer, M. J., Willett, W. C., & Hu, F. B. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02044-2 · Cited by 225 · cited 1×
“In the reports with a significant association, many have used CHD death as an end point (4,5,7,8), suggesting that a unique mechanism may exist between type 2 diabetes and coronary death.”
BackgroundNelson, R. G., Sievers, M. L., Knowler, W. C., Swinburn, B. A., Pettitt, D. J., Saad, M. F., Liebow, I. M., Howard, B. V., & Bennett, P. H. (1990) · Circulation · doi:10.1161/01.cir.81.3.987 · Cited by 181
Detre, K. M., Lombardero, M. S., Brooks, M. M., Hardison, R. M., Holubkov, R., Sopko, G., Frye, R. L., & Chaitman, B. R. (2000) · New England Journal of Medicine · doi:10.1056/nejm200004063421401 · Cited by 171
Jarrett, R. J., & Shipley, M. J. (1988) · Diabetologia · doi:10.1007/bf00274775 · Cited by 168
Gerstein, H. C., Mann, J. F. E., Pogue, J., Dinneen, S. F., Hallé, J., Hoogwerf, B., Joyce, C., Rashkow, A. M., Young, J. B., Zinman, B., et al. (2000) · PubMed · Cited by 152
The prevalence of multiple diabetes‐related complications
Morgan, C. L., Currie, C. J., Stott, N. C. H., Smithers, M., Butler, C., & Peters, J. R. (2000) · Diabetic Medicine · doi:10.1046/j.1464-5491.2000.00222.x · Cited by 146
Diabetes duration and cause-specific mortality in the Verona Diabetes Study.
Brun, E., Nelson, R. G., Bennett, P. H., Imperatore, G., Zoppini, G., Verlato, G., Muggeo, M., & Study, V. D. (2000) · Diabetes Care · doi:10.2337/diacare.23.8.1119 · Cited by 135
Association of Diabetes Mellitus with Coronary Atherosclerosis and Myocardial Lesions
Burchfiel, C. M., REED, D. M., Marcus, E. B., Strong, J. P., & Hayashi, T. (1993) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116642 · Cited by 88
Impact of NIDDM on Mortality and Causes of Death in Pima Indians
Sievers, M. L., Nelson, R. G., Knowler, W. C., & Bennett, P. H. (1992) · Diabetes Care · doi:10.2337/diacare.15.11.1541 · Cited by 64
Macrovascular Complications in Mexican Americans With Type II Diabetes
Haffner, S. M., Mitchell, B. D., D, M. P. S. M., & Hazuda, H. P. (1991) · Diabetes Care · doi:10.2337/diacare.14.7.665 · Cited by 37
Cited by
Heart Disease and Stroke Statistics—2012 Update: A Report From the American Heart Association
Writing Group Members, Roger, V. L., Go, A. S., Lloyd-Jones, D. M., Benjamin, E. J., Berry, J. D., Borden, W. B., Bravata, D. M., Dai, S., Ford, E. S., et al. (2012) · Circulation · doi:10.1161/cir.0b013e31823ac046 · Cited by 7,333
Self-citationHeart Disease and Stroke Statistics—2011 Update: A Report From the American Heart Association
Roger, V. L., Go, A. S., Lloyd-Jones, D. M., Adams, R. J., Berry, J. D., Brown, T. M., Carnethon, M. R., Dai, S., de Simone, G., Ford, E. S., et al. (2011) · Circulation · doi:10.1161/cir.0b013e3182009701 · Cited by 6,149
Self-citationHeart Disease and Stroke Statistics—2010 Update: A Report From the American Heart Association
WRITING GROUP MEMBERS, Lloyd-Jones, D., Adams, R. J., Brown, T. M., Carnethon, M., Dai, S., De Simone, G., Ferguson, T. B., Ford, E., Furie, K., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.192667 · Cited by 5,700
WRITING GROUP MEMBERS, Lloyd-Jones, D., Adams, R., Carnethon, M., De Simone, G., Ferguson, T. B., Flegal, K., Ford, E., Furie, K., Go, A., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.191259 · Cited by 3,908
Writing Group Members, Rosamond, W., Flegal, K., Furie, K., Go, A., Greenlund, K., Haase, N., Hailpern, S. M., Ho, M., Howard, V., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.187998 · Cited by 3,711
Metadata
- Authors
- Fox, C. S., Sullivan, L., D’Agostino, R. B., & Wilson, P. W. F.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2004-03-01
- Volume
- 27
- Issue
- 3
- Pages
- 704-708
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2145730981
- Cited by
- 317
- References
- 31
- FWCI
- 6.49
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.